611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Growth Rates of Small Renal Masses Highly Variable Early OnLearning Problems May Accompany Kidney DiseasePoorer Kids May Fare Worse After Heart SurgeryRisk Factors for Recurrence of Acute Diverticulitis IdentifiedClues to Parkinson's May Be Shed in TearsToo Much TV Could Boost Your Odds for a Blood ClotAspirin, Rivaroxaban Similar After Total Hip, Knee ArthroplastyAspirin as Good a Clot Buster as Pricey Drugs After Joint ReplacementHealth Tip: Understanding Palliative CareDrug That Eases Rheumatoid Arthritis Pain Won't Help 'Regular' ArthritisAnticoagulants in Seniors With A-Fib, CKD Ups Stroke, ICH RiskHerbal Drug Kratom Linked to Salmonella Illnesses, CDC SaysHealth Tip: Understanding TonsillitisHealth Tip: Do You Need a Tetanus Shot?Obesity Might Cause Sudden Cardiac Arrest in the YoungLung Cancer One of Many Reasons Not to SmokeLong-Term Inhaled Corticosteroid Use May Raise Fracture RiskKids Who Need Sickle Cell Meds Don't Always Get Them1 in 10 Worldwide Gets Wound Infection After Abdominal SurgeryCould a Blood Thinner Actually Raise Stroke Risk for Some?Health Tip: When Arthritis Strikes Your FeetFDA Approves First Blood Test to Evaluate Potential ConcussionsHealth Tip:Living with Pulmonary FibrosisFood Allergies: To Test or Not to TestAsthma Doesn't Have to Ruin Your Valentine's DayHealth Tip :Preparing for SurgeryKidney Stones on the Rise Among WomenOpioid Use Linked to Risk of Invasive Pneumococcal DiseaseThink Extermination Ends Your Bedbug Woes? Think AgainUnsafe Water Found in Faucets Across the U.S.Another Downside to Opioid Use: Pneumonia?It May Be Winter, But Keep That Sunscreen HandyAcne Linked to Increased Risk of Major Depressive DisorderHealth Tip: Signs You Need Rotator Cuff SurgeryHealth Tip: Controlling PinkeyeHead Injuries Hit 1 in 14 Kids, CDC ReportsICD Placement Doesn't Improve Survival in Patients With CKDAre Germs Falling From the Sky?More Norovirus Infections at Olympics in South KoreaVery Low-Calorie Diet Prompts Brief Heart Function DropExpenditures Rising for Treating Obesity-Related Illness in U.S.Defibrillators May Not Help Kidney Patients With Bad HeartsImpotence Among Heart Patients Not the Fault of Meds, Study FindsHealth Tip: Symptoms of Iron-Deficiency AnemiaAsthma Attacks on the Decline Among U.S. KidsPossible Link Found Between Poor Diet and Back InjuriesA Hidden Source of 'Superbugs' in Hospitals?'Hole in Heart' Defect May Raise Stroke Risk After SurgeryHealth Tip: Common Signs of SinusitisEasing Your Child's Asthma
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Serum Caffeine, Metabolites May Predict Early Parkinson's Disease


HealthDay News
Updated: Jan 3rd 2018

new article illustration

WEDNESDAY, Jan. 3, 2018 (HealthDay News) -- Serum levels of caffeine and its metabolites could be diagnostic biomarkers for early Parkinson's disease (PD), according to a study published online Jan. 3 in Neurology.

Motoki Fujimaki, M.D., from the Juntendo University School of Medicine in Tokyo, and colleagues examined the kinetics and metabolism of caffeine in serum from 108 patients with PD and 31 age-matched healthy controls. Levels of caffeine and its 11 metabolites were examined by liquid chromatography-mass spectrometry. Direct sequencing was conducted to screen for mutations in caffeine-associated genes.

The researchers observed significant decreases in serum levels of caffeine and nine of its downstream metabolites, even in patients with early PD, which were unrelated to total caffeine intake or severity of disease. Compared with controls, there were no significant variations in CYP1A2 or CYP2E1, encoding cytochrome P450 enzymes involved in metabolizing caffeine. Patients with PD with motor complications had significantly decreased caffeine concentrations compared to PD patients without motor complications. There were no correlations between disease severity and single nucleotide variants of the ADORA2A gene encoding adenosine 2A receptor. In receiver operating characteristic curve analysis, the profile of serum caffeine and metabolite levels was identified as a potential diagnostic biomarker.

"Absolute lower levels of caffeine and caffeine metabolite profiles are promising diagnostic biomarkers for early PD," the authors write. "This is consistent with the neuroprotective effect of caffeine previously revealed by epidemiologic and experimental studies."

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)